Respiratory therapy

Drug/DM	Brand name	INN	Pharmaceutical form	Strengths	Primary packaging	Therapeutic area	CTD Dossier availability	GMP	Climatic zone
MD, II class	Lorde^® HYAL / Nasisoft^® Forte	Sodium Chloride 3%, Hyaluronic acid	solution for inhalation and intranasal administration	30 mg/ml, 4 ml	single-dose polymer containers	Pulmonology, therapy, pediatrics	CE certificate	N/A	IVb
MD, II class	Nasisoft^®	Sodium Chloride 0,9%, Hyaluronic acid	solution for inhalation and intranasal administration	9 mg/ml, 4 ml	single-dose polymer containers	Pulmonology, therapy, pediatrics	CE certificate	N/A	IVb
MD, II class	Okistar^® HYAL /Nasisoft^® Extra	Sodium Chloride 7%, Hyaluronic acid	solution for inhalationn	70 mg/ml, 4 ml	single-dose polymer containers	Pulmonology, therapy, pediatrics	CE certificate	N/A	IVb
MD, II class	Breather Treat^®	Sodium Chloride 3%	solution for inhalation and intranasal administration	30 mg/ml, 4 ml	single-dose polymer containers	Pulmonology, therapy, pediatrics		N/A	IVb
MD, II class	Breather Barrier^®	Sodium Chloride 0,9%	solution for inhalation and intranasal administration	9 mg/ml, 4 ml	single-dose polymer containers	Pulmonology, therapy, pediatrics		N/A	IVb
Drug	Оzelaіr^®	Caffeine citrate	Solution for infusion and oral use	20 mg/ml, 1 ml	Ampules	Pulmonology, neonatology	Q4 2026	UA - available	IVb
MD, I class	Snotty^®	Xylitol 12% + Sodium Chloride 0,9%	Solution for intranasal administration	120 mg/ml, 30 ml	Plastic container with spray pump	Pulmonology, therapy, pediatrics	CE certificate - by request	N/A	II
MD, II class	Snotty^®	Xylitol 12% + Sodium Chloride 0,9%	Solution for intranasal administration	120 mg/ml, 2 ml	Single-dose polymer containers	Pulmonology, therapy, pediatrics	CE certificate - by request	N/A	II